Omnispirant Limited

Transforming medicine through the development of first-in-class regenerative gene therapies.

Omnispirant Limited was founded in 2016, is headquartered in Indianapolis, Ireland, lists 1–10 employees, and has $220K in recorded funding across 4 rounds.

Headquarters
Indianapolis
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$220K
Last Round
SeedJan 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

OmniSpirant is an Ireland-based early-stage therapeutics company developing a novel platform technology based on inhaled stem cell exosomes (OmniSomes) for treating respiratory diseases and cancer. The company's proprietary OmniSome technology combines regenerative medicine and gene therapy, leveraging naturally occurring extracellular vesicles to achieve 30–40x more efficient gene transfer than synthetic lipid nanoparticles. OmniSpirant has partnered with Aerogen Limited to optimize inhaled delivery formulations and demonstrated in vivo gene transfer in small animal models, targeting rare respiratory conditions including cystic fibrosis.

Summary

Omnispirant Limited is a Healthcare company based in Indianapolis, Ireland, founded in 2016. It lists 1–10 employees. It has raised $220K in total across 4 rounds, most recently a Seed round in Jan 2025. Investors include Emily's Entourage and Horizon 2020 SME Instrument.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2025

Sign up to see all 4 events

Funding: Grant through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Omnispirant Limited on Indexed.vc
<a href="https://indexed.vc/companies/omnispirant-limited"><img src="https://indexed.vc/api/badge/company/omnispirant-limited" alt="Omnispirant Limited on Indexed.vc" width="260" height="76" /></a>